Draegerwerk AG & Co. KGaA · XETR:DRW8
Draegerwerk AG & Co. KGaA — Drägerwerk AG & Co. KGaA — Q2 2005 Earnings Presentation
19 slides from Draegerwerk AG & Co. KGaA's earnings presentation, Aug 11, 2005
Slide 1: Drägerwerk AG Conference Call
Drägerwerk AG »Technology for Life« Conference Call August 11, 2005 1 August, 05
Slide 2: Highlights 2nd Quarter 2005 – Dräger Medical
Highlights 2nd Quarter 2005 DRÄGER MEDICAL • Operating order entry and net sales double-digit above previous year - USA with order entry plus 26 % • Higher than proportional increase in EBIT • Innovation push continues - Launch of anaesthesia system ´Apollo´ for the US market • Expenses for R&D cont
Slide 3: Q2-Report Dräger Medical
Q2-Report Dräger Medical 01.04.- 30.06.2005, IFRS SALES AND EARNINGS/ mn € Q2/2005 Q2/ 2004 Change Order entry 281.7 236.2 + 19.3% Net sales 265.9 236.3 + 12.5% Operating EBIT * 22.2 17.8 + 24.7% Operating EBIT margin 8.3% 7.5% Capital employed 569.0 507.0 + 12.2% Net debt -87.8 -153.0 + 42.6% 1) Be
Slide 4: H1-Report Dräger Medical
H1-Report Dräger Medical 01.01.- 30.06.2005, IFRS SALES AND EARNINGS/ mn € H1/2005 H1/2004 Change Order entry 545.3 457.4 + 19.2% Net sales 492.1 436.5 + 12.7% Operating EBIT * 34.1 27.8 + 22.7% Operating EBIT margin 6.9% 6.4% Capital employed 569.0 507.0 + 12.2% Net debt -87.8 -153.0 + 42.6% 1) Bef
Slide 5: Highlights 2nd Quarter 2005 – Dräger Safety
Highlights 2nd Quarter 2005 DRÄGER SAFETY • Growth based on volume as well as on project business • Growth regions - Asia/Pacific + 17.2 % (order entry) - Europe + 10.3 % (net sales) - Germany + 10.0 % (net sales) • Expenses for R&D continuously on a high level - 11.9 mn €, 4.5 % of net sales 5 Augu
Slide 6: Q2-Report Dräger Safety
Q2-Report Dräger Safety 01.04.- 30.06.2005, IFRS SALES AND EARNINGS/ mn € Q2/2005 Q2/2004 Change Order entry 141.3 129.0 + 9.5% Net sales 141.1 1) 127.6 + 10.6% Operating EBIT 12.9 11.7 + 10.3% Operating EBIT margin 9.1% 9.2% Capital employed 190.0 170.3 + 11.6% Net debt 39.3 25.5 + 54.1% 1) Incl. 6
Slide 7: H1-Report Dräger Safety
H1-Report Dräger Safety 01.01.- 30.06.2005, IFRS SALES AND EARNINGS/ mn € H1/2005 H1/2004 Change Order entry 277.7 261.8 + 6.1% Net sales 264.3 1) 240.9 + 9.7% Operating EBIT 24.0 2) 21.3 + 12.7% Operating EBIT margin 9.1% 8.8% Capital employed 190.0 170.3 + 11.6% Net debt 39.3 25.5 + 54.1% 1) Incl.
Slide 8: Q2-Report Dräger Group
Q2-Report Dräger Group 01.04.- 30.06.2005, IFRS SALES AND EARNINGS/ mn € Q2/2005 Q2/2004 Change Order entry 414.3 365.6 + 13.3% Net sales 398.5 362.2 + 10.0% Operating EBIT 1) 29.6 27.1 + 9.2% EBIT margin 7.4% 7.5% Net income 13.0 11.4 + 14.0% Capital employed 845.5 748.0 + 13.0% Net debt 274.0 177.
Slide 9: H1-Report Dräger Group
H1-Report Dräger Group 01.01.- 30.06.2005, IFRS SALES AND EARNINGS/ mn € H1/2005 H1/2004 Change Order entry 806.8 717.0 + 12.5% Net sales 739.9 675.0 + 9.6% Operating EBIT 1) 47.6 44.9 + 6.0% EBIT margin 6.4% 6.7% Net income 2) 17.9 27.1 - 33.9% Capital employed 845.5 748.0 + 13.0% Net debt 274.0 17
Slide 10: H1-Report Dräger Group
H1-Report Dräger Group 01.01.- 30.06.2005, IFRS SALES AND EARNINGS/ mn € H1/2005 H1/2004 +/- Order entry 806.8 717.0 + 12.5% Net sales 739.9 675.0 + 9.6% Cost of goods sold (COGS) -371.5 -335.5 + 10.7% Gross profit 368,4 339.5 + 8.5% Gross margin 49.8% 50.3% Functional cost -317.5 -299.5 + 6.0% Fina
Slide 11: Key Figures / Consolidated Balance Sheet (Assets)
H1-Report Dräger Group Key Figures/ Consolidated Balance Sheet (IFRS) ASSETS/ mn € 30.06.2005 31.12.2004 Intangible assets 177.1 176.5 Property, plant and equipment 193.0 189.2 Other non-current assets 26.3 30.4 Deferred taxes 82.6 76.9 Non-current assets 479.0 473.0 Inventories 312.0 260.4 Trade re
Slide 12: Key Figures / Consolidated Balance Sheet (Equity and Liabilities)
H1-Report Dräger Group Key Figures/ Consolidated Balance Sheet (IFRS) EQUITY AND LIABILITIES/ mn € 30.06.2005 31.12.2004 Equity 482.6 477.3 Participation capital 74.8 74.8 Pension provisions 157.5 155.5 Long-term loans 104.0 107.4 Other non-current provisions and liabilities 25.9 24.5 Deferred taxes
Slide 13: Outlook
H1-Report Dräger Group Outlook mn € 31.12.2004 Guidance 2005 Dräger Medical Net sales 1,023 + 5-7 % Operating EBIT 94 + 5-10 % Dräger Safety Net sales 503 + 5-7 % Operating EBIT 41 + 5-10 % Dräger Konzern Net sales 1,521 + 5-7 % Operating EBIT 117 + 5-10 % Net profit 47 + 5-10 % 13 August, 05
Slide 14: Appendix
Appendix 14 August, 05
Slide 15: Reconciliation of Equity by June 30, 2004
H1-Bericht Dräger Konzern Reconciliation of Equity by June 30, 2004 mn € 30.06.2004 Equity under HGB (incl. minority interests) 520.0 Asset-backed securities -2.8 Recognition of internally developed Software 2.2 Goodwill 3.4 Valuation adjustment of components/ adjustment of depreciation -1.9 Recogni
Slide 16: Reconciliation of Net Income by June 30, 2004
H1-Bericht Dräger Konzern Reconciliation of Net Income by June 30, 2004 mn € 30.06.2004 Net income under HGB (incl. minority interests) 25.2 Recognition/Valuation adjustment of internally developed Software -0.4 Valuation adjustment of components/ adjustment of depreciation -0.2 Inventory measuremen
Slide 17: Reconciliation of Equity by December 31, 2003
Dräger Group Reconciliation of Equity by December 31, 2003 mn € 01.01.2003 31.12.2003 Equity under HGB (incl. minority interests) 170.133 499.182 Asset-backed securities -2.677 -2.618 Recognition of internally developed software 2.983 2.607 Goodwill -3.214 115 Valuation adjustment of components/adju
Slide 18: Reconciliation of Net Income by December 31, 2003
Dräger Group Reconciliation of Net Income by December 31, 2003 mn € 2003 Net income under HGB (incl. minority interests) 37.807 Recognition/valuation adjustment of internally developed software -376 Goodwill 666 Valuation adjustment of components/adjustment of depreciation -428 Recognition of financ
Slide 19: Disclaimer
Disclaimer Estimates: This presentation contains a number of forecasts and estimates which are based on present expectations, anticipations and predictions on the part of the Executive Board and the information it currently has. Such estimates should not be construed as a warranty that the future de
Drägerwerk AG & Co. KGaA — Q2 2005 Earnings Presentation on 6ix